{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:47:51Z","timestamp":1787165271917,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.redox.2021.101855","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T03:35:56Z","timestamp":1610249756000},"page":"101855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY"],"prefix":"10.1016","volume":"40","author":[{"given":"Xiaojing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Man","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghou","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.redox.2021.101855_bib1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/dc14-2769","article-title":"Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation","volume":"38","author":"Chakera","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.redox.2021.101855_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/nyas.13588","article-title":"Precision medicine in diabetes: an opportunity for clinical translation","volume":"1411","author":"Merino","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.redox.2021.101855_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00125-013-3075-x","article-title":"Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia","volume":"57","author":"Stride","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2021.101855_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.metabol.2018.09.004","article-title":"Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients","volume":"89","author":"Liu","year":"2018","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.redox.2021.101855_bib5","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2337\/dc19-0486","article-title":"The impact of biomarker screening and cascade genetic testing on the cost-effectiveness of MODY genetic testing","volume":"42","author":"GoodSmith","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.redox.2021.101855_bib6","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/db13-1878","article-title":"Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3","volume":"63","author":"Ostoft","year":"2014","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.redox.2021.101855_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2337\/db19-0324","article-title":"Iatrogenic hyperinsulinemia, not hyperglycemia, drives insulin resistance in type 1 diabetes as revealed by comparison with GCK-MODY (MODY2)","volume":"68","author":"Gregory","year":"2019","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.redox.2021.101855_bib8","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2337\/dc18-0253","article-title":"Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study","volume":"41","author":"Leiva-Gea","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.redox.2021.101855_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jama.2013.283980","article-title":"Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia","volume":"311","author":"Steele","year":"2014","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.redox.2021.101855_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11892-014-0559-0","article-title":"Glucokinase MODY and implications for treatment goals of common forms of diabetes","volume":"14","author":"Ajjan","year":"2014","journal-title":"Curr. Diabetes Rep."},{"issue":"24","key":"10.1016\/j.redox.2021.101855_bib11","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.redox.2021.101855_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.redox.2021.101855_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db12-0827","article-title":"Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2)","volume":"62","author":"Spegel","year":"2013","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.redox.2021.101855_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00125-019-4959-1","article-title":"New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism","volume":"62","author":"Eid","year":"2019","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.redox.2021.101855_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00592-014-0567-1","article-title":"Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level","volume":"51","author":"Fendler","year":"2014","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.redox.2021.101855_bib16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s13300-019-0647-x","article-title":"Using clinical indices to distinguish MODY2 (GCK mutation) and MODY3 (HNF1A mutation) from type 1 diabetes in a young Chinese population","volume":"10","author":"Fu","year":"2019","journal-title":"Diabetes Ther"},{"issue":"11","key":"10.1016\/j.redox.2021.101855_bib17","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/dc19-0100","article-title":"High-coverage targeted lipidomics reveals novel serum lipid predictors and lipid pathway dysregulation antecedent to type 2 diabetes onset in normoglycemic Chinese adults","volume":"42","author":"Lu","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.redox.2021.101855_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","article-title":"Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis","volume":"32","author":"Song","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2021.101855_bib19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.redox.2017.05.002","article-title":"Sequestration of polyunsaturated fatty acids in membrane phospholipids of Caenorhabditis elegans dauer larva attenuates eicosanoid biosynthesis for prolonged survival","volume":"12","author":"Lam","year":"2017","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.redox.2021.101855_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1194\/jlr.M044826","article-title":"Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles","volume":"55","author":"Lam","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.redox.2021.101855_bib21","series-title":"Improving Coverage of the Plasma Lipidome Using Iterative MS\/MS Data Acquisition Combined with Lipid Annotator Software and 6546 LC\/Q-TOF","author":"Sartain","year":"2019"},{"issue":"11","key":"10.1016\/j.redox.2021.101855_bib22","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/clinchem\/23.11.2089","article-title":"New micromethod for measuring cholesterol in plasma lipoprotein fractions","volume":"23","author":"Bronzert","year":"1977","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.redox.2021.101855_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.atherosclerosis.2015.05.037","article-title":"Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL","volume":"241","author":"Sutter","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.redox.2021.101855_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.atherosclerosis.2015.06.040","article-title":"Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration","volume":"241","author":"Denimal","year":"2015","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.redox.2021.101855_bib25","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1210\/jc.2016-3429","article-title":"Variation in maturity-onset diabetes of the young genes influence response to interventions for diabetes prevention","volume":"102","author":"Billings","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.redox.2021.101855_bib26","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1091\/mbc.01-11-0540","article-title":"The major sites of cellular phospholipid synthesis and molecular determinants of Fatty Acid and lipid head group specificity","volume":"13","author":"Henneberry","year":"2002","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.redox.2021.101855_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11745-002-0947-6","article-title":"PC and PE synthesis: Mixed micellar analysis of the cholinephosphotransferase and ethanolaminephosphotransferase activities of human choline\/ethanolamine phosphotransferase 1 (CEPT1)","volume":"37","author":"Wright","year":"2002","journal-title":"Lipids"},{"issue":"5","key":"10.1016\/j.redox.2021.101855_bib28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","article-title":"Phosphatidylcholine biosynthesis and lipoprotein metabolism","volume":"1821","author":"Cole","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.redox.2021.101855_bib29","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s00125-007-0808-8","article-title":"HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation","volume":"50","author":"Persegol","year":"2007","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.redox.2021.101855_bib30","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1210\/jc.2003-031897","article-title":"Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients","volume":"89","author":"Ferretti","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.redox.2021.101855_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tra.12230","article-title":"Phospholipid synthesis and transport in mammalian cells","volume":"16","author":"Vance","year":"2015","journal-title":"Traffic"},{"issue":"Pt 2","key":"10.1016\/j.redox.2021.101855_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/bj3390291","article-title":"Cloning and expression of a human choline\/ethanolaminephosphotransferase: synthesis of phosphatidylcholine and phosphatidylethanolamine","volume":"339","author":"Henneberry","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2021.101855_bib33","series-title":"Phospholipid Synthesis in Mammalian Cells","first-page":"209","author":"Ridgway","year":"2016"},{"issue":"38","key":"10.1016\/j.redox.2021.101855_bib34","doi-asserted-by":"crossref","first-page":"29808","DOI":"10.1074\/jbc.M005786200","article-title":"Cloning, genomic organization, and characterization of a human cholinephosphotransferase","volume":"275","author":"Henneberry","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.redox.2021.101855_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0962-8924(98)01281-1","article-title":"Phosphatidylinositol transfer proteins: the long and winding road to physiological function","volume":"8","author":"Kearns","year":"1998","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.redox.2021.101855_bib36","doi-asserted-by":"crossref","first-page":"G1067","DOI":"10.1152\/ajpgi.00194.2005","article-title":"Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins","volume":"289","author":"Wu","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7611","key":"10.1016\/j.redox.2021.101855_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature18628","article-title":"TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis","volume":"535","author":"Hsieh","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101855_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2018.01.037","article-title":"Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: a cross-sectional study in chronic kidney disease patients","volume":"270","author":"Maeba","year":"2018","journal-title":"Atherosclerosis"},{"issue":"9841","key":"10.1016\/j.redox.2021.101855_bib39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.redox.2021.101855_bib40","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1194\/jlr.P068585","article-title":"Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia","volume":"57","author":"Orsoni","year":"2016","journal-title":"J. Lipid Res."},{"issue":"21","key":"10.1016\/j.redox.2021.101855_bib41","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","article-title":"Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus","volume":"134","author":"Alshehry","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2021.101855_bib42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.redox.2017.04.032","article-title":"Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases","volume":"12","author":"Lu","year":"2017","journal-title":"Redox Biol"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:18:07Z","timestamp":1761977887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":42,"alternative-id":["S2213231721000033"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.101855","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.101855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101855"}}